tirzepatide cv outcomes trial Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist for type 2 diabetes: A systematic review and meta-analysis Tirzepatide and Cardiovascular Outcomes: A

If this describes your situation and youre taking Ozempic, you need to make a clear decision

The appetite suppression and metabolic benefits create an environment where building healthier habits is dramatically easier

The synergy between these compounds addresses the primary limitation of GLP-1 medications: losing muscle alongside fat

Are comfortable with a newer drug still undergoing studies for obesity treatment

Mechanistic sub-study embedded in an efficacy trial + Incorporate GSM/dryness endpoints (validated questionnaires, clinician assessment, pH) into semaglutide RCTs or pragmatic trials, with pre-specified subgroup analyses by menopausal status and HRT use

To manage this, consume protein during times of day when nausea is minimal, choose cold or room-temperature proteins which may be better tolerated, incorporate ginger or peppermint tea, and consider anti-nausea medications if symptoms are severe